Results 121 to 130 of about 37,376 (192)

Protective efficacy of a genetically modified attenuated vaccinia virus Tiantan strain against monkeypox virus challenge in a small animal model. [PDF]

J Virol
Su W, Zhao T, Ren X, Li S, Huang Q, Liu J, Zhang X, Ge Z, Wei J.   +8 more
europepmc   +1 more source

Mpox and the one health approach. [PDF]

Dialogues Health
Zargar AA.
europepmc   +1 more source

Mpox Epidemics: A Call to Restore Humanity's Lost Herd Immunity to Orthopoxviruses. [PDF]

Viruses
Wayengera M, Kyobe-Bosa H, Muttamba W, Olu OO, Gueye AS, Ndembi N, Kamara N, Folayan MO, Kirenga B, Luo S, Li Q, Ihekweazu C.   +11 more
europepmc   +1 more source

Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden. [PDF]

Open Forum Infect Dis
Espinosa-Gongora C, Christ W, Mayola Danés N, Eichler-Jonsson C, Filén F, Storgärd E, Westergren V, Klingström J, Gredmark-Russ S, Johansen K, Ekström AM, Sondén K.   +11 more
europepmc   +1 more source

Emerging threats of monkeypox virus in 2024: current insights and future directions. [PDF]

Future Sci OA
L S D, R D, A M, N H, Begum RF, S N, M M, S AS.   +7 more
europepmc   +1 more source

Sero-neutralizing antibody against orthopoxviruses in populations of Wuhan, China. [PDF]

Mol Biomed
Gao Z, Liu T, Zhao Z, Wang B, Hou L.
europepmc   +1 more source

Outbreak dates of virus could be predicted by their protein sequence. [PDF]

J Transl Med
Zuo P, Zuo L, Li Z, Zhou X, Yu Y, Wu Q, Niu Y, Chang Q, Rabie ABM, Lam P, Li L.   +10 more
europepmc   +1 more source

Neurological complications of Orthopoxvirus infections: neurotropism and neurovirulence. [PDF]

Brain
Miranzadeh Mahabadi H, Noyce RS, Evans DH, Power C.   +3 more
europepmc   +1 more source

Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks. [PDF]

Viruses
Orkin C, Torgler R, Dawson R, Holloway IW, Hoffmann C.   +4 more
europepmc   +1 more source